Table 3.
Outcome | Model | C‐Index (95% CI) |
---|---|---|
MACE | Model 1 | 0.636 (0.620–0.652) |
Model 1+IL‐6 | 0.654 (0.639–0.669) | |
MCE | Model 1 | 0.624 (0.608–0.640) |
Model 1+IL‐6 | 0.639 (0.623–0.655) | |
Cardiovascular death | Model 1 | 0.731 (0.710–0.753) |
Model 1+IL‐6 | 0.755 (0.735–0.775) | |
MI | Model 1 | 0.632 (0.610–0.654) |
Model 1+IL‐6 | 0.641 (0.618–0.663) | |
Stroke | Model 1 | 0.649 (0.614–0.684) |
Model 1+IL‐6 | 0.657 (0.622–0.692) | |
Heart failure | Model 1 | 0.764 (0.738–0.789) |
Model 1+IL‐6 | 0.793 (0.768–0.817) | |
Total death | Model 1 | 0.711 (0.694–0.728) |
Model 1+IL‐6 | 0.739 (0.723–0.755) | |
Cancer death | Model 1 | 0.708 (0.668–0.747) |
Model 1+IL‐6 | 0.742 (0.704–0.780) |
CI indicates confidence interval; IL‐6, interleukin‐6; MACE, major adverse cardiovascular event; MCE, major coronary event; MI, myocardial infarction.